DXM (dextromethorphan) can be addictive, though its addiction profile differs from classic drugs of abuse like opioids or stimulants. At standard cough-suppressing doses, addiction risk is low. But at the high doses used recreationally, DXM produces dissociative and euphoric effects that can lead to compulsive use, tolerance, and psychological dependence over time.
How DXM Affects the Brain
DXM is classified as a semi-synthetic opioid, but it doesn’t work like typical painkillers. Instead of activating opioid receptors in a way that produces strong pain relief or the classic opioid high, it primarily blocks NMDA receptors, the same type of receptor targeted by ketamine and PCP. This is what produces the dissociative, out-of-body effects that recreational users seek.
Interestingly, DXM on its own doesn’t appear to directly spike dopamine in the brain’s reward center. Animal research has shown that even moderately high doses of DXM alone didn’t change dopamine levels in the nucleus accumbens, the region most associated with reward and addiction. That said, DXM does modulate the dopamine pathway indirectly, and it acts on serotonin and sigma receptors in ways that alter mood and perception. These combined effects create a complex neurochemical picture that, for some people, becomes reinforcing enough to drive repeated use.
Tolerance Builds With Regular Use
One of the clearest signs that DXM has addictive potential is that tolerance develops. People who use it regularly need progressively higher doses to reach the same level of intoxication. A case study published in the Journal of Medical Toxicology documented a man who used DXM for over 10 years, steadily escalating his doses over that period. His blood work showed a gradual, persistent increase in bromide concentrations (a byproduct of the drug’s formulation), providing objective evidence that his body had adapted to the drug and he was consuming more and more to compensate.
This pattern of escalation is a hallmark of substance use disorders. The person starts at a dose that produces the desired effect, finds that dose less effective over weeks or months, and increases it. Each increase carries greater risk of toxicity.
Psychological Dependence and Compulsive Use
Physical withdrawal from DXM is less well-documented than withdrawal from alcohol or opioids. But psychological dependence is a real and often underestimated component. People who misuse DXM frequently describe intense cravings, unsuccessful attempts to quit, and continued use despite obvious harm to their relationships, work, or health.
Substance use disorders are diagnosed on a spectrum of severity based on 11 criteria. These include taking more of a substance than intended, spending excessive time obtaining or recovering from it, continuing use despite social or physical consequences, and feeling a strong urge or craving to use. Meeting two or three criteria qualifies as a mild disorder, four or five as moderate, and six or more as severe. People with chronic DXM misuse patterns often meet several of these criteria, particularly around impaired control and continued use despite negative consequences.
Recreational Dose Levels and Escalation
Recreational DXM use is often described in “plateaus,” each representing a higher dose range and a more intense set of effects. At the lowest recreational level (roughly 1.5 to 2.5 mg per kilogram of body weight), users report mild stimulation and euphoria. The second plateau (2.5 to 7.5 mg/kg) brings stronger dissociation and perceptual changes. The third plateau (7.5 to 15 mg/kg) produces intense hallucinations and a near-complete disconnect from surroundings. Beyond 15 mg/kg, users enter a state sometimes compared to a “k-hole” from ketamine, with complete dissociation and significant risk of medical emergency.
For context, a standard therapeutic dose of DXM for cough is about 0.3 mg/kg. Even the lowest recreational plateau involves taking five to eight times the recommended amount. As tolerance builds, users often progress from lower plateaus to higher ones, chasing the intensity of earlier experiences.
Long-Term Cognitive Damage
Chronic DXM misuse doesn’t just carry addiction risk. It can cause lasting harm to brain function. Acute toxicity symptoms include slurred speech, loss of coordination, nystagmus (involuntary eye movements), disorientation, and aggressive behavior. With prolonged abuse, these effects can become more than temporary. Case reports have documented cognitive deterioration in long-term users, with deficits in attention, memory, and executive function that persist beyond the period of active use.
DXM also inhibits serotonin reuptake, meaning high doses or frequent use can trigger serotonin syndrome, a potentially life-threatening condition involving agitation, high body temperature, rapid heart rate, and muscle rigidity. This risk increases significantly when DXM is combined with antidepressants or other serotonin-active drugs.
Hidden Dangers in OTC Formulations
One of the most serious risks specific to DXM misuse comes not from DXM itself but from the other active ingredients in cough and cold products. Many formulations combine DXM with acetaminophen, antihistamines, or decongestants. At therapeutic doses, these additives are safe. At the massive doses needed for a recreational DXM experience, they become dangerous.
Acetaminophen is the biggest concern. It is toxic to the liver at high doses, and acetaminophen poisoning can cause irreversible liver damage or death. Someone taking 10 or 20 times the recommended dose of a combination cough syrup to get a DXM high may be simultaneously ingesting a lethal amount of acetaminophen. Antihistamines at high doses cause anticholinergic toxicity, leading to dangerously elevated heart rate, confusion, seizures, and hyperthermia. These co-ingredient risks make DXM misuse more physically dangerous than the DXM alone would be.
Shared Pathways With Other Dissociatives
DXM, ketamine, PCP, and methoxetamine all bind to NMDA receptors and produce overlapping patterns of intoxication. Someone who develops tolerance to one of these substances may have partial tolerance to the others, a phenomenon known as cross-tolerance. This shared mechanism also means that the compulsive use patterns seen with ketamine and PCP can apply to DXM as well. The dissociative experience itself, the feeling of detachment from reality and one’s body, can become psychologically compelling for people dealing with stress, trauma, or mental health conditions, creating a reinforcing cycle that’s difficult to break.
The accessibility of DXM makes this particularly concerning. Unlike ketamine or PCP, DXM is sold over the counter in pharmacies and grocery stores, making it one of the easiest dissociative substances to obtain. This low barrier to access contributes to its misuse, especially among adolescents and young adults.